Africa faces the heaviest burden of endemic diseases in the world; with just over 15% of the global population, the continent accounts for 50% of maternal deaths and 67% of HIV/AID cases. Out-of-pocket health spending in Africa remains excessively high compared to other continents, illustrating that the need to finance the continent’s healthcare systems was pressing well before COVID-19 took hold. Nevertheless, the pandemic exposed underlying systematic weaknesses inherent in the healthcare sector on the continent, emphasising the urgent need to develop core strength in healthcare across the entire value chain to ensure that these systems can become more accessible, sustainable, and resilient.
In addition to increased urbanisation rates, Africa's share of the global population is estimated to increase to 25% by 2050. As economies across the continent continue to recover the demand for higher-quality healthcare will only increase further. Investment in medical infrastructure and the healthcare workforce will prove essential in building a pipeline of technical expertise on the ground to drive Africa’s biotech industry while addressing youth employment. A greater focus on thought leadership in Africa's growing youth population will be critical to unlocking the capital confined to real estate.
Running Order:
08:30 - 09:00 Breakfast & Networking
09:00 - 09:15 Knight Frank Report (presentation)
09:15 - 10:15 Panel Discussion & Q&A
10:15 - 10:30 Networking
To register for the event please contact charlotte.kemp@investafrica.com
Event Partner:
Head of Consumer & Industrials | British International Investment (BII)
Partner - Healthcare & Education | Knight Frank
President & CEO | KKM Global Healthcare Group